Company intelligence / Profile preview
Phylex BioSciences
Del Mar, California, United Statesprnewswire.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Preclinical
01
Overview
Phylex BioSciences has developed a novel mRNA nanoparticle vaccine against the Nipah virus that demonstrated robust immunogenicity in preclinical mouse studies, with neutralizing antibody titers significantly higher than those seen in survivors of natural infection. The company’s technology aims to induce long-lasting immunity with single-dose efficacy. Their COVID program uses similar technology targeting current variants and immune imprinting issues.
- Therapeutic areas
- Infectious Diseases
- Modalities
- mRNA vaccines (mRNA nanoparticle vaccines)Virus-like particles (VLPs) (for SARS-CoV and related work)
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
Request access →03
Partnerships
ATUM – collaboration on cell line development/manufacturing platforms for universal coronavirus vaccines.U.S. Centers for Disease Control and Prevention (CDC) – scientific collaboration on preclinical studies of the Nipah vaccine candidate.
Beyond the preview
Go deeper on Phylex BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phylex BioSciences.